Clinical Trials Browser

NIH × Leukemia, Large Granular Lymphocytic × Alemtuzumab × Clear all

NCT00345345 2022-05-03

Alemtuzumab (Campath) to Treat T-Large Granular Lymphocyte Leukemia

Phase 2 Completed

29 enrolled 17 charts

Other hematologic neoplasm

Leukemia, Neutropenia, Leukemia, Large Granular Lymphocytic